CAPA Letter on Draft Canadian Drug Pricing Guidelines

CAPA Letter on Draft Canadian Drug Pricing Guidelines

Access to the right medicines is an important component in managing arthritis. In Canada, the Patented Medicines Prices Review Board (PMPRB) plays a key role in drug pricing in Canada. On July 1, 2020, the newly amended Patented Medicines Regulations will come into...
en_USEnglish
Powered by TranslatePress